Effects of berberine on rat jejunal motility

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 5, 2013, Pages 734-744

  Chen, Da Peng ^a   Xiong, Yong Jian ^a   Lv, Bo Chao ^a   Liu, Fang Fei ^a   Wang, Li ^a   Tang, Ze Yao ^a   Lin, Yuan ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

alternating type irritable bowel syndrome; berberine; Ca2+; contractile state; enteric nervous system

Indexed keywords

BERBERINE; CALCIUM ION; MESSENGER RNA; MYOSIN; MYOSIN LIGHT CHAIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; DRUG MECHANISM; EX VIVO STUDY; EXTRACELLULAR CALCIUM; GENE EXPRESSION; INTESTINE INNERVATION; INTESTINE MOTILITY; JEJUNUM; NONHUMAN; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; RAT;

ADRENERGIC AGENTS; ANIMALS; ARGININE; ATROPINE; BERBERINE; BERBERIS; CALCIUM; CHOLINERGIC AGENTS; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL MOTILITY; IRRITABLE BOWEL SYNDROME; JEJUNUM; MUSCLE CONTRACTION; MYOSIN-LIGHT-CHAIN KINASE; MYOSINS; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TETRODOTOXIN; VERAPAMIL;

EID: 84876489514     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12026     Document Type: Article

References (30)

1. Kuo CL, et al. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 2004; 2: 127-137.
2. Jantova S, et al. Berberine induces apoptosis through a mitochondrial/caspase pathway in human promonocytic U937 cells. Toxicol in Vitro 2007; 21: 25-31.
3. Amin AH, et al. Berberine sulfate: antimicrobial activity, bioassay, and mode of action. Can J Microbiol 1969; 15: 1067-1076.
4. Basha SA, et al. Effect of berberine and (+/-)-bicuculline isolated from Corydalis chaerophylla on spore germination of some fungi. Folia Microbiol 2002; 2: 161-165.
5. Hwang BY, et al. Antimicrobial constituents from goldenseal (the rhizomes of Hydrastis canadensis) against selected oral pathogens. Planta Med 2003; 7: 623-627.
6. Nakamoto K, et al. Effects of crude drugs and berberine hydrochloride on the activities of fungi. J Prosthet Dent 1990; 6: 691-694.
7. Okunade AL, et al. Antimicrobial properties of alkaloids from Xanthoriza simplicissima. J Pharm Sci 1994; 83: 404-406.
8. Tai YH, et al. Antisecretory effects of berberine in rat ileum. Am J Physiol 1981; 3: 253-258.
9. Takase H, et al. Pharmacological studies on antidiarrheal effects of berberine and geranii herba. Folia Pharmacol Jpn 1993; 2: 101-112.
10. Schemann M,. Control of gastrointestinal motility by the 'gut brain'-the enteric nervous system. J Pediatr Gastroenterol Nutr 2005; 41: S4-S6.
11. Pimentel M,. The treatment of patients with irritable bowel syndrome: review of the latest data from the 2010 DDW meeting. Gastroenterol Hepatol (NY) 2010; 6: 1-15.
12. 7 receptor in brain and intestine in rats with irritable bowel syndrome. Chin Med J 2007; 120: 2069-2074.
13. La JH, et al. Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis. World J Gastroenterol 2003; 9: 2791-2795.
14. 4 agonist-tegaserod. BMC Gastroenterol 2006; 6: 1-9.
15. 2. J Vet Med A Physiol Pathol Clin Med 2000; 47: 469-475.
16. Koji K, et al. Prostaglandin E2-prostanoid EP3 signal induces vascular contraction via nPKC and ROCK activation in rat mesenteric artery. Eur J Pharmacol 2011; 660: 3375-3380.
17. Iwabu A, et al. Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C δ-dependent Pathway. J Biol Chem 2004; 279: 14551-14560.
18. Li M, et al. Cholinergic and nitrergic regulation of in vivo giant migrating contractions in rat colon. Am J Physiol Gastrointest Liver Physiol 2002; 283: G544-G552.
19. Konturek SJ, Siebers R,. Role of histamine H1- and H2-receptors in myoelectric activity of small bowel in the dog. Am J Physiol 1980; 238: G50-G56.
20. West GB,. Adrenaline and noradrenaline. J Pharm Pharmacol 1955; 7: 81-98.
21. Mang CF, et al. Modulation by NO of acetylcholine release in the ileum of wild-type and NOS gene knockout mice. Am J Physiol Gastrointest Liver Physiol 2002; 283: G1132-G1138.
22. Ihara E, Macdonald JA,. The regulation of smooth muscle contractility by zipper-interacting protein kinase. Can J Physiol Pharmacol 2007; 85: 79-87.
23. He WQ, et al. Myosin light chain kinase is central to smooth muscle contraction and required for gastrointestinal motility in mice. Gastroenterology 2008; 135: 610-620.
24. Blair SA, et al. Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest 2006; 86: 191-201.
25. Wang F, et al. Interferon-gamma and tumor necrosis factor-α synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 2005; 166: 409-419.
26. Alaina J, et al. Smooth muscle myosin light chain kinase content is increased in human sensitized airways. Am J Respir Crit Care Med 2000; 161: 257-263.
27. Liu W, et al. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury. Eur J Pharmacol 2010; 638: 150-155.
28. Luo Y, et al. Berberine inhibits cyclin D1 expression via suppressed binding of AP-1 transcription factors to CCND1 AP-1 motif. Acta Pharmacol Sin 2008; 29: 628-633.
29. Graham WV, et al. Tumor necrosis factor-induced long myosin light chain kinase transcription is regulated by differentiation-dependent signaling events. Characterization of the human long myosin light chain kinase promoter. J Biol Chem 2006; 281: 26205-26215.
30. Goldstein AM, Nagy N,. A bird's eye view of enteric nervous system development: lessons from the avian embryo. Pediatr Res 2008; 64: 326-333.